Sample Question 2
A 54-year-old man is admitted to the neuro ICU after severe traumatic brain injury with diffuse cerebral edema. He develops worsening intracranial hypertension despite head-of-bed elevation, analgesia/sedation optimization, and CSF drainage. Current data: ICP 28 mm Hg, CPP 64 mm Hg, MAP 82 mm Hg, serum sodium 126 mEq/L, serum osmolality 282 mOsm/kg, SCr 2.3 mg/dL (baseline 0.9 mg/dL), urine output 0.3 mL/kg/hr for the last 6 hours, and BP has been intermittently labile with brief hypotension overnight. Which hyperosmolar strategy is most appropriate now?
- Administer hypertonic saline
- Administer mannitol
- Use either agent because both are equally appropriate
- Avoid hyperosmolar therapy because the serum osmolality is normal
Rationale
Answer choice A is correct
- Correct: "Administer hypertonic saline" — Hypertonic saline is the best choice because this patient has acute brain injury with intracranial hypertension plus significant hyponatremia, acute kidney injury, oliguria, and intermittent hemodynamic instability. Hypertonic saline both raises serum sodium and increases serum tonicity, which is desirable in hyponatremia-associated cerebral edema and intracranial pressure elevation. In contrast, mannitol can worsen intravascular volume depletion, provoke hypotension through osmotic diuresis, and accumulates in renal dysfunction, increasing toxicity risk. In neurocritical care, hypertonic saline is generally favored over mannitol when treatment goals include sodium correction, when renal function is impaired, or when maintaining hemodynamic stability is important.
- "Administer mannitol" — Mannitol is an accepted hyperosmolar agent for elevated intracranial pressure, but it is not the best option here. The patient is hyponatremic, so mannitol would not address the low serum sodium driving cerebral water shift. It also causes osmotic diuresis and may worsen hypotension or renal injury, which is problematic in a patient with AKI, oliguria, and recent labile blood pressure.
- "Use either agent because both are equally appropriate" — Both agents can reduce intracranial pressure, but they are not equally appropriate in this specific scenario. The stem supplies distinguishing factors that favor hypertonic saline: hyponatremia, renal dysfunction, oliguria, and concern for hemodynamic tolerance. A single-best-answer question is justified because these variables materially change agent selection.
- "Avoid hyperosmolar therapy because the serum osmolality is normal" — Normal baseline serum osmolality does not preclude hyperosmolar treatment for intracranial hypertension. The treatment decision is driven by elevated ICP and the overall clinical context. In this patient, hypertonic saline is appropriate specifically because it can safely increase tonicity while also correcting hyponatremia.
High-Yield Core Concept
When choosing between hypertonic saline and mannitol for cerebral edema, integrate serum sodium, renal function, urine output, hemodynamics, and the therapeutic goal; hypertonic saline is often preferred when hyponatremia, AKI, or hypotension risk is present.
High-Yield Fast Fact
Mannitol lowers ICP by creating an osmotic gradient but can cause osmotic diuresis and worsen hypovolemia or kidney injury; hypertonic saline is especially useful when sodium augmentation is itself part of the treatment goal.
References
- Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020;32(3):647-666. doi:10.1007/s12028-020-00959-7
- Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017;80(1):6-15. doi:10.1227/NEU.0000000000001432